An Observational Study of Patients Treated With Bimatoprost 0.03% (Latisse®) for Hypotrichosis of the Eyelashes

Allergan585 enrolled

Overview

This is an observational study of patients treated with bimatoprost 0.03% (Latisse®) for at least 12 months for hypotrichosis of the eyelashes.

Study Type

OBSERVATIONAL

Enrollment

585

Conditions

Eyelash Hypotrichosis

Interventions

bimatoprost 0.03%DRUG

Subjects with hypotrichosis of the eyelashes using bimatoprost 0.03% (Latisse®) as prescribed by physician for at least 12 months

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Hypotrichosis of the eyelashes * Using bimatoprost ophthalmic solution 0.03% (Latisse®) for at least 12 months Exclusion Criteria: * Use of any over-the-counter medication(s) for eyelash growth

Locations (1)

Unnamed facility

Santa Ana, California, United States

Outcomes

Primary Outcomes

Percentage of Subjects Satisfied With Latisse®

Overall subject satisfaction with Latisse® was assessed on a 5-point scale (Very Satisfied, Satisfied, Neutral, Unsatisfied, and Very Unsatisfied). The percentage of subjects satisfied and very satisfied is reported.

Time frame: Day 1

Secondary Outcomes

Number of Applications of Latisse® Per Week

Number of applications of Latisse® per week as reported by the subjects.

Time frame: Day 1

Percentage of Subjects Satisfied Wtih Their Eyelashes

Overall subject satisfaction with their eyelashes was assessed on a 5-point scale (Very Satisfied, Satisfied, Neutral, Unsatisfied, and Very Unsatisfied). The percentage of subjects satisfied and very satisfied is reported.

Time frame: Day 1

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.